Psoriasis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Psoriasis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{Reflist|2}..." |
m Bot: Removing from Primary care |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Psoriasis}} | {{Psoriasis}} | ||
{{CMG}} | |||
==Overview== | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Dermatology]] | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] |
Latest revision as of 23:52, 29 July 2020
Psoriasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Psoriasis cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Psoriasis cost-effectiveness of therapy |
Risk calculators and risk factors for Psoriasis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]